Medtech
This function is exclusive for Premium subscribers
-
DATABASE (98)
-
ARTICLES (64)
Xange is the venture capital arm of Siparex Group, with offices in Paris and Munich. It is dedicated to supporting entrepreneurs in disruptive digital, deep tech and social impact. It has €450m under management and 65 startups in its portfolio.
Xange is the venture capital arm of Siparex Group, with offices in Paris and Munich. It is dedicated to supporting entrepreneurs in disruptive digital, deep tech and social impact. It has €450m under management and 65 startups in its portfolio.
Founded in 2002, Galia Gestion is an investment fund based in Bordeaux and operating principally in southwest France. To date, it has supported some 150 companies and currently has €100m of investments under management.
Founded in 2002, Galia Gestion is an investment fund based in Bordeaux and operating principally in southwest France. To date, it has supported some 150 companies and currently has €100m of investments under management.
Founded in 2003 in New York, Vast Ventures has invested in over 70 early-stage companies, with a focus on companies tackling global problems or which are rooted in sustainability. It has managed 22 exits to date. It currently has 45 companies in its portfolio, the overwhelming majority of which are based in the Americas. Its most recent investments include participation in the May 2021 $8m seed round for Chilean rental management proptech player Houm, as well as the April 2021 $17m Series A round of MedChart, a Canadian healthcare data systems startup.
Founded in 2003 in New York, Vast Ventures has invested in over 70 early-stage companies, with a focus on companies tackling global problems or which are rooted in sustainability. It has managed 22 exits to date. It currently has 45 companies in its portfolio, the overwhelming majority of which are based in the Americas. Its most recent investments include participation in the May 2021 $8m seed round for Chilean rental management proptech player Houm, as well as the April 2021 $17m Series A round of MedChart, a Canadian healthcare data systems startup.
Capricorn Investment Group is one of the world’s largest mission-aligned investment companies, managing more than $6bn in multi-asset class portfolios for families, foundations and institutional investors. Notably, it manages the investment portfolio of Jeff Skoll, the first President of eBay, and his charitable organization. The company has offices in Silicon Valley and New York. It has invested in 63 companies to date, many aimed at tackling key challenges facing our world today. It has managed 14 exits to date, including Tesla. Its main focus is on technology and sustainability, with a particular interest in deeptech, aerospace, transport, agtech, healthcare and energy. The firm’s most recent disclosed investments were in May 2021, via participation in the $100m Series B round of Canadian quantum computing startup Xanadu and the $28m Series B round of US geothermal tech company Fervo Energy.
Capricorn Investment Group is one of the world’s largest mission-aligned investment companies, managing more than $6bn in multi-asset class portfolios for families, foundations and institutional investors. Notably, it manages the investment portfolio of Jeff Skoll, the first President of eBay, and his charitable organization. The company has offices in Silicon Valley and New York. It has invested in 63 companies to date, many aimed at tackling key challenges facing our world today. It has managed 14 exits to date, including Tesla. Its main focus is on technology and sustainability, with a particular interest in deeptech, aerospace, transport, agtech, healthcare and energy. The firm’s most recent disclosed investments were in May 2021, via participation in the $100m Series B round of Canadian quantum computing startup Xanadu and the $28m Series B round of US geothermal tech company Fervo Energy.
Founded in 2015 in Guatemala City, the Invariantes Fund invests in technology startups based in the US and Latin America, across different market segments. It is the only VC based in Guatamala, and bills itself as the country’s first early-stage VC firm. As of June 2021, its portfolio includes 24 startups. Invariantes’ most recent investments include participation in the $21m Series A round of US edtech player Reforge, as well in the $130m Series B round of US-based Axiom Space, which is building the first international commercial space station. Both investments were in February 2021.
Founded in 2015 in Guatemala City, the Invariantes Fund invests in technology startups based in the US and Latin America, across different market segments. It is the only VC based in Guatamala, and bills itself as the country’s first early-stage VC firm. As of June 2021, its portfolio includes 24 startups. Invariantes’ most recent investments include participation in the $21m Series A round of US edtech player Reforge, as well in the $130m Series B round of US-based Axiom Space, which is building the first international commercial space station. Both investments were in February 2021.
Focused on life sciences, OrbiMed has been investing in the global healthcare industry for over 20 years. Its portfolio ranges from early-stage startups to multinational corporations. With more than 100 scientific, medical, and investment professionals, it manages over $17bn assets worldwide.
Focused on life sciences, OrbiMed has been investing in the global healthcare industry for over 20 years. Its portfolio ranges from early-stage startups to multinational corporations. With more than 100 scientific, medical, and investment professionals, it manages over $17bn assets worldwide.
Prosperity7 Ventures is the $1bn diversified VC fund of Aramco Ventures, a subsidiary of Aramco, the world's leading integrated energy and chemicals company. The fund's name derives from “Prosperity Well", the 7th oil well drilled in Saudi Arabia and the first to strike oil. Prosperity7 Ventures invests globally, focusing on highly scalable startups in the US and China.
Prosperity7 Ventures is the $1bn diversified VC fund of Aramco Ventures, a subsidiary of Aramco, the world's leading integrated energy and chemicals company. The fund's name derives from “Prosperity Well", the 7th oil well drilled in Saudi Arabia and the first to strike oil. Prosperity7 Ventures invests globally, focusing on highly scalable startups in the US and China.
Founded in Boston in 2019, Transformation is entirely dedicated to healthcare disruption, predominently focuses on US investments and typically invests $10-30m per startup. It currently has 22 companies in its portfolio. Its most recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and, the same month, in the $21m Series D round of Protenus, the US’ leading healthcare compliance analytics firm.
Founded in Boston in 2019, Transformation is entirely dedicated to healthcare disruption, predominently focuses on US investments and typically invests $10-30m per startup. It currently has 22 companies in its portfolio. Its most recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and, the same month, in the $21m Series D round of Protenus, the US’ leading healthcare compliance analytics firm.
Founded in 1997 in London, Amadeus has invested in more than 130 companies, has over 40 employees and has raised over $1bn to date. The investor focuses on early-stage UK-based companies, although it has also invested in later-stage European and developing market startups. In August 2021, it announced a $150m upcoming investment drive in Brazil. Amadeus currently has 54 portfolio companies. Its recent investments include the June 2021 £20m Series A investment round of UK-based XYZ Reality that employs holograms in construction tech. In May 2021, it led the $4.8m investment in the cryptography lifecycle management platform Cryptosense.
Founded in 1997 in London, Amadeus has invested in more than 130 companies, has over 40 employees and has raised over $1bn to date. The investor focuses on early-stage UK-based companies, although it has also invested in later-stage European and developing market startups. In August 2021, it announced a $150m upcoming investment drive in Brazil. Amadeus currently has 54 portfolio companies. Its recent investments include the June 2021 £20m Series A investment round of UK-based XYZ Reality that employs holograms in construction tech. In May 2021, it led the $4.8m investment in the cryptography lifecycle management platform Cryptosense.
Founded in London in 2009, Parkwalk is a specialist investor in deeptech spin-offs created at UK universities. Parkwalk currently has over £375m of assets under management and has invested in over 100 companies to date, emanating from the universities in Oxford, Cambridge, Imperial and Bristol, becoming the UK’s most active VC outside London. It currently has 143 portfolio companies, Its recent investments include the $17m May 2021 Series A round of cell therapy medtech Mogrify and in the April 2021 £1.9m seed round of HexagonFab, a medtech producing analytical lab instruments.
Founded in London in 2009, Parkwalk is a specialist investor in deeptech spin-offs created at UK universities. Parkwalk currently has over £375m of assets under management and has invested in over 100 companies to date, emanating from the universities in Oxford, Cambridge, Imperial and Bristol, becoming the UK’s most active VC outside London. It currently has 143 portfolio companies, Its recent investments include the $17m May 2021 Series A round of cell therapy medtech Mogrify and in the April 2021 £1.9m seed round of HexagonFab, a medtech producing analytical lab instruments.
Founded in 2017, Suzhou Longmen Ventures mainly invests in businesses working on innovative drugs and medical devices. It manages tens of billions RMB in assets.
Founded in 2017, Suzhou Longmen Ventures mainly invests in businesses working on innovative drugs and medical devices. It manages tens of billions RMB in assets.
Founded in 2018, Linden Asset Group currently has offices in Nanjing, Shenzhen and Singapore. With both US dollar- and RMB-denominated funds under management, it is focused on the fields of biotechnology, medtech and smart technology in the Asia Pacific region. Linden Asset prefers growth-stage startups that are cutting-edge in their respective areas and plans for overseas expansion.
Founded in 2018, Linden Asset Group currently has offices in Nanjing, Shenzhen and Singapore. With both US dollar- and RMB-denominated funds under management, it is focused on the fields of biotechnology, medtech and smart technology in the Asia Pacific region. Linden Asset prefers growth-stage startups that are cutting-edge in their respective areas and plans for overseas expansion.
With New Hope Group, one of China’s biggest agriculture and food businesses, as its cornerstone investor, HosenCare Brothers had operated as a PE arm within the group for nearly a decade. In 2017, it began to operate under its current name. It currently manages assets worth more than RMB 3bn, and mainly invests in sectors of medtech, healthcare, biotechnology and smart manufacturing.
With New Hope Group, one of China’s biggest agriculture and food businesses, as its cornerstone investor, HosenCare Brothers had operated as a PE arm within the group for nearly a decade. In 2017, it began to operate under its current name. It currently manages assets worth more than RMB 3bn, and mainly invests in sectors of medtech, healthcare, biotechnology and smart manufacturing.
Established in 2003, JW Medical Systems (JWMS) is a wholly-owned subsidiary of high-end medical consumables manufacturer Bluesail. It’s an international company focusing on the R&D, manufacturing and marketing of high-tech interventional products. JWMS has offices in Beijing, Shanghai, Guangzhou, Shenyang and Xi'an.
Established in 2003, JW Medical Systems (JWMS) is a wholly-owned subsidiary of high-end medical consumables manufacturer Bluesail. It’s an international company focusing on the R&D, manufacturing and marketing of high-tech interventional products. JWMS has offices in Beijing, Shanghai, Guangzhou, Shenyang and Xi'an.
Founded in London in 1998, Kreos Capital is a pioneer growth debt provider. Kreos has completed over 630 deals worth over €3bn in pan-European countries and Israel. The Kreos Capital Group of companies and various funds are regulated by the Jersey Financial Services Commission.Kreos currently has 102 companies in its portfolio and has managed over 200 exits. Investee Riskified, an Israeli e-commerce fraud protection company, was listed on the NYSE at a $3.3bn valuation in August 2021. Kreos also joined recent investments in 2021 including the $54m Series B round of Austrian refurbished electronics goods marketplace Refurbed and the €9.5m round of Berlin-based HRtech expertlead.
Founded in London in 1998, Kreos Capital is a pioneer growth debt provider. Kreos has completed over 630 deals worth over €3bn in pan-European countries and Israel. The Kreos Capital Group of companies and various funds are regulated by the Jersey Financial Services Commission.Kreos currently has 102 companies in its portfolio and has managed over 200 exits. Investee Riskified, an Israeli e-commerce fraud protection company, was listed on the NYSE at a $3.3bn valuation in August 2021. Kreos also joined recent investments in 2021 including the $54m Series B round of Austrian refurbished electronics goods marketplace Refurbed and the €9.5m round of Berlin-based HRtech expertlead.
SWITCH Singapore 2021: How to harness the power of the deep tech ecosystem
Investor Jason Illian of Koch Disruptive Technologies talks talent, scaling for deep tech startups, and why longer gestation periods and mid-course pivots don’t have to be deal breakers
SWITCH Singapore 2021: Benefits and challenges of AI applications in healthcare
Medical experts and healthcare startups agree AI can contribute more to healthcare beyond improving diagnosis and personalized treatment, but hurdles still remain
Sequoia China Seed Fund: Growing an era of deep-tech startups
Managing Partner Neil Shen wants to help deep-tech and enterprise tech startups get investments more easily, across quantum computing, semiconductors, synthetic biology and more
South Summit 2021: Martin Varavsky, Leandro Sigman on post-Covid healthcare trends
Serial entrepreneur Martin Varavsky and Insud Pharma Chairman Leandro Sigman share their thoughts and projections on the future of health tech
Intudo Ventures: Grooming returning overseas talent for an Indonesia-only bet
Combining the experience and networks of foreign-educated Indonesians with local distribution channels, Intudo’s hyperlocal strategy has attracted $200m in managed assets
ARTICARES: Personalized, more affordable arm rehab therapy at home
Using adaptive AI, its H-Man robot works like an occupational therapist, assessing patient’s performance and adjusting the complexity of training tasks in real time
Sequoia Capital China holds steady with investments in healthcare, biotech and green economy
China’s most active investor increases bets on sectors beyond the consumer internet and edtech recently hurt by regulatory clampdown
New sectors, strategies come into play as investors respond to China's Big Tech curbs
Amid the crackdown on China’s tech giants, some investors are sussing out less risky sectors, while heavyweights like BlackRock and Fidelity stay in for the long haul
Aimentia: Pioneering mental health AI SaaS seeks to improve diagnosis as demand surges
Barcelona-based Aimentia supports the oft-overlooked mental health segment through digitalization and analytics, going beyond therapy platforms
Zoundream: Deciphering and mining the data in baby cries
The world’s first algorithm to translate baby cries into actionable insights for parents and hospitals seeks to boost early detection of pathologies and developmental disorders
Nuuk, the cooler box poised to disrupt cold chain logistics
Barcelona-based startup Groenlandia Tech has developed a smart cooler box to track and monitor biological samples, providing an extra layer of security and control during transport
Vence: Virtual fencing for sustainable livestock rearing
The startup uses GPS and AI algorithms to create virtual fences that work with animal collars for more efficient management of livestock and grasslands
TreeFrog Therapeutics: Mimicking how stem cells grow in the human body
The French biotech’s proprietory technology to cultivate pluripotent stem cells in a 3D environment can be scaled to mass-produce high-quality cells to treat diseases such as Parkinson’s
Therapixel: Using AI to improve breast cancer detection
Therapixel is raising €15m for commercial expansion of its AI-powered MammoScreen that gives accurate breast cancer screening results within minutes
HumanITcare: Covid-19 spurs demand for telemedicine across Spain and beyond
The startup’s revenue is expected to exceed €10m by 2024 due to rapid digital transformation of healthcare services and a growing market for AI-powered medtechs
POPULAR DATABASE
